中泰证券：第三季度有望迎来医疗器械板块阶段性拐点

Core Viewpoint - The domestic medical device industry in China is still in a rapid development phase, with short-term negative impacts from medical insurance cost control, but the outlook remains positive due to innovation-driven import substitution and globalization [1] Group 1: Industry Outlook - The medical device sector is expected to experience a phase shift by the third quarter of 2025 as multiple negative impacts are fully released [1] - Continuous support for domestic enterprises through policy and innovation is enhancing competitiveness and accelerating import substitution [1] Group 2: Investment Opportunities - There is optimism regarding companies that are successfully expanding into overseas markets [1] - The industry is encouraged to focus on investment opportunities in AI healthcare and brain-computer interface technologies [1]